HDAC Inhibitory and Anti-Cancer Activities of Curcumin and Curcumin Derivative CU17 against Human Lung Cancer A549 Cells

Previous research reported that the curcumin derivative (CU17) inhibited several cancer cell growths in vitro. However, its anticancer potential against human lung cancer cells (A549 cell lines) has not yet been evaluated. The purpose of this research was to examine the HDAC inhibitory and anti-canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Namwan, Narissara, Senawong, Gulsiri, Phaosiri, Chanokbhorn, Kumboonma, Pakit, Somsakeesit, La-or, Samankul, Arunta, Leerat, Chadaporn, Senawong, Thanaset
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268269/
https://www.ncbi.nlm.nih.gov/pubmed/35807258
http://dx.doi.org/10.3390/molecules27134014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9268269/
https://www.ncbi.nlm.nih.gov/pubmed/35807258
http://dx.doi.org/10.3390/molecules27134014

Ejemplares similares